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Introduction: Chronic renal failure (CRF) patients present inability
of the kidney to maintain normal product of protein metabolism,
blood pressure and hematocrit, and also the control of sodium,
water, potassium and acid-base balance. Cellular and humoral im-
mune response and can be depressed so the existence of disorders in
oral health may represent foccus of infection. According the liter-
ature patients under hemodialysis have a 40-50-fold increased risk
of mortality from sepsis compared with the general population. The
monitoring of opportunistic viruses is an extreme importance, since
they are related to comorbidities in these individuals. The objective
of this study was to analyze the presence of human herpesviruses
(HSV1, HSV2, VZV, EBV, CMV, HHV6, HHV7 and HHV8) in saliva
of CRF patients.
Methods: 105 individuals divided into 3 groups according to the
stage of renal disease. Group 1 (n¼13) control group; Group 2
(n¼53) patients with chronic renal disease and group 3 (n¼33) end-
stage renal disease (ESRD) patients in hemodialysis. For saliva
collection was used the technique of salivary ﬂow non-stimulated.
Samples were evaluated by multiplex PCR for herpesviruses.
Results: The herpesviruses CMV, HSV-2, and HHV-8 were not
found in any of the saliva samples. The distribution of herpesvi-
ruses in the study patients is shown in Table 1. The comparison of
the prevalence of HSV-1 between group 3 and 2 showed signiﬁcant
difference (p ¼ 0.0307). EBV, VZV, HHV-6 and HHV-7 did not
show any difference.
Table 1. Distribution of herpesviruses in the 3 groups (number of
patients and percentage)
GROUP N NEGATIVE HSV-1 EBV VZV HHV-6 HHV-7S101 13 3 (23.07 1 (7.69) 7 (53.84) 0 1 (7.69) 7 (53.84)2 53 18 (33.96) 4 (7.54) 25 (47.16) 3 (5.66) 4 (7.54 26 (49.05)3 33 9 (27.27) 8 (24.24) 18 (54.54) 4 (12.12) 1 (3.03) 17 (51.51)The most prevalent co-infection was EBV/HHV-7 detected in
40% of all patients. The distribution of the co-infection of the 3
groups are shown in Table 2. The statistical analysis did not show
difference between the groups, but we detected the association of
the HSV-1/EBV/HHV-7 just in the group 3.
Table 2 - Herpesviruses co-infection in saliva samples (number of
patients and percentage).
HSV-1/ EBV/ HHV- EBV/HHV-6/ EBV/VZV/HHV- HSV-1/EBV/HHV-
GROUP N EBV 7 HHV-7 7 71 10 1 (10.00) 3 (30.00) 1 (10.00) 0 02 35 1 (2.85) 15 (42.85) 15 (42.85) 2 (5.71) 03 24 2 (8.33) 5 (20.83) 5 (20.83) 2 (8.33) 5 (20.83)Conclusions: With the results obtained we can conclude that
serological screening for herpesvirus in chronic renal failurepatients and hemodialysis , which are transplant candidates is
essential to determine its been immune. The prevalence of co-
infection in hemodialysis patients as HSV -1 / EBV / HHV -7 can
cause complications in these patients.
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Introduction: Primary hyperoxaluria is a condition characterized by
overproduction of oxalate. When available in excess, oxalate
combines with calcium to form crystals of calcium oxalate leading
to kidney stone disease. NLRP3 inﬂammasome-mediated renal
inﬂammation was identiﬁed as a prime pathomechanism of acute
oxalate nephropathy (Mulay et. al., JCI 2013) as well as kidney
stone disease (Knauf et. al., KI 2013). In addition, a recent report
demonstrated that -hydroxybutyrate (BHB) inhibited NLRP3-
mediated inﬂammation (Youm YH et. al., Nat Med 2015). Therefore,
we speculated that BHB would ameliorate calcium oxalate (CaOx)
crystals-induced NLRP3-mediated inﬂammation in acute oxalate
nephropathy as well as primary hyperoxaluria related kidney stone
disease.
Methods: C57BL/6 mice at the age of 6-to 8-week old were pur-
chased from Charles River, which received a single intraperitoneal
injection of 100 mg/kg sodium oxalate for the acute calcium oxalate
nephropathy model and kidneys were harvested after 24 hours. For
the chronic model, mice were fed with a low calcium plus Na-
Oxalate diet. In both models, mice were fed with a ketogenic diet
(KD) containing 1,3 butanodiol ketone diesters for 5-7 days before
induce kidney damage. Urine and blood samples were collected at
different time intervals (before and at 3, 7 and 14 days after damage)
and kidneys were used for RNA isolation and histological analysis
(IHC). The kidney function was quantiﬁed by the glomerular
ﬁltration rate (GFR), plasma creatinine and BUN levels at indicated
times. Markers of kidney damage (Kim-1), inﬂammation (IL-6,
MCP-1, RANTES, TNF-) and ﬁbrotic markers (SMA, Col1A1, FSP-1,
Fib-1) were analyzed by RT-PCR and IHC. The BHB levels were
assayed in serum samples with a colorimetric assay kit (Cayman
Chemicals. MI, USA).
Results: We observed that BHB inhibited CaOx crystals-induced
NLRP3-mediated IL-1ß release from bone marrow derived dendritic
cells in a dose dependent manner in vitro. Moreover, feeding of
ketogenic diet (KD) to C57Bl6 mice elevated their plasma BHB levels
and protected them from acute oxalate nephropathy as seen by
decreased plasma BUN and creatinine levels despite similar renal
crystal deposition. KD also reduced tubular injury (PAS, Kim-1),
renal neutrophil inﬁltration and renal inﬂammation (IL-6, TNF,
RANTES and CXCL2) during acute oxalate nephropathy. Similarly,
KD did not change the renal CaOx crystal deposition and plug
formation during kidney stone disease, however still protected mice
from progressive renal failure as seen by improvement in glomer-
ular ﬁltration rate (GFR) and decreased plasma BUN and creatinine
levels. Elevated plasma BHB levels after KD administrationKidney International Reports (2016) 1, S1–S22
